Immunomedics (IMMU) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts IMMU Hot Sheet
Join SI Premium – FREE
Immunomedics (NASDAQ: IMMU) reported Q1 EPS of ($0.16), $0.02 worse than the analyst estimate of ($0.14).
For earnings history and earnings-related data on Immunomedics (IMMU) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
- Biogen (BIIB) tops earnings expectations but revenue falls short
- Magyar Bancorp (MGYR) Reports Q2 EPS of $0.30
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
